Mesothelial‐to‐mesenchymal transition in the pathogenesis of post‐surgical peritoneal adhesions
Pilar Sandoval(Consejo Superior de Investigaciones Científicas), Manuel López‐Cabrera(Consejo Superior de Investigaciones Científicas), María Luisa Pérez‐Lozano(Inserm), Javier Dotor(SOM Biotech (Spain)), María José Coronado(Hospital Universitario Puerta de Hierro Majadahonda), Ángela Rynne‐Vidal(Centro de Biología Molecular Severo Ochoa), Pedro Majano(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Abelardo Aguilera Peralta(Hospital Universitario de La Princesa), Carmen Bárcena(Universidad Complutense de Madrid), Patricia Albar-Vizcaíno(Hospital Universitario de La Princesa), Paloma Martín(Hospital Universitario Puerta de Hierro Majadahonda), Gonzalo Guerra-Azcona(Clínica Girona), José A. Jiménez‐Heffernan(Hospital Universitario de La Princesa), Fernando Gil-Vera(Clínica Girona)
Cited by 119
Related Papers
Carcinoma‐associated fibroblasts derive from mesothelial cells via mesothelial‐to‐mesenchymal transition in peritoneal metastasis
|The Journal of Pathology|2013|183
Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-κB/Snail1 pathway
|Disease Models & Mechanisms|2008|118
Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
|The Journal of Pathology|2017|114
Caveolin‐1 deficiency induces a MEK‐ERK1/2‐Snail‐1‐dependent epithelial–mesenchymal transition and fibrosis during peritoneal dialysis
|EMBO Molecular Medicine|2014|92
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis
|Digestive and Liver Disease|2021|62